Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
15
CRI Quote, Financials, Valuation and Earnings
Last price:
$30.42
Seasonality move
:
-0.19%
Day range:
$29.67 - $31.08
52-week range:
$29.36 - $71.99
Dividend yield:
8.78%
P/E ratio:
6.68x
P/S ratio:
0.38x
P/B ratio:
1.30x
Volume:
1.4M
Avg. volume:
1.5M
1-year change:
-51.82%
Market cap:
$1.1B
Revenue:
$2.8B
EPS (TTM):
$4.52
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | $3.5B | $3.2B | $2.9B | $2.8B | |
| Revenue Growth (YoY) | -14.06% | 15.28% | -7.85% | -8.32% | -3.45% | |
| Cost of Revenues | $1.7B | $1.8B | $1.7B | $1.5B | $1.5B | |
| Gross Profit | $1.3B | $1.7B | $1.5B | $1.4B | $1.4B | |
| Gross Profit Margin | 43.43% | 47.68% | 45.83% | 47.39% | 48% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.1B | $1.2B | $1.1B | $1.1B | $1.1B | |
| Other Inc / (Exp) | -$44.6M | $409K | -$29.9M | $8M | -$33.6M | |
| Operating Expenses | $1.1B | $1.2B | $1.1B | $1.1B | $1.1B | |
| Operating Income | $234.1M | $497.1M | $388.2M | $323.4M | $284.7M | |
| Net Interest Expenses | $54.5M | $59.2M | $41.5M | $29.2M | $20.3M | |
| EBT. Incl. Unusual Items | $135M | $438.3M | $316.7M | $302.2M | $230.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $25.3M | $98.5M | $66.7M | $69.7M | $45.3M | |
| Net Income to Company | $109.7M | $339.7M | $250M | $232.5M | $185.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $109.7M | $339.7M | $250M | $232.5M | $185.5M | |
| Basic EPS (Cont. Ops) | $2.51 | $7.83 | $6.34 | $6.24 | $5.12 | |
| Diluted EPS (Cont. Ops) | $2.50 | $7.81 | $6.34 | $6.24 | $5.12 | |
| Weighted Average Basic Share | $43.2M | $42.9M | $38.8M | $36.6M | $35.5M | |
| Weighted Average Diluted Share | $43.4M | $43M | $38.9M | $36.6M | $35.5M | |
| EBITDA | $285M | $592.7M | $424.8M | $400.4M | $320.1M | |
| EBIT | $191M | $498.6M | $359.5M | $336.2M | $262.1M | |
| Revenue (Reported) | $3B | $3.5B | $3.2B | $2.9B | $2.8B | |
| Operating Income (Reported) | $234.1M | $497.1M | $388.2M | $323.4M | $284.7M | |
| Operating Income (Adjusted) | $191M | $498.6M | $359.5M | $336.2M | $262.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $787.4M | $781.3M | $695.9M | $661.5M | $629.8M | |
| Revenue Growth (YoY) | 20.31% | -0.77% | -10.93% | -4.94% | -4.79% | |
| Cost of Revenues | $395.4M | $426.2M | $386.4M | $346.3M | $338.7M | |
| Gross Profit | $392M | $355M | $309.5M | $315.2M | $291.1M | |
| Gross Profit Margin | 49.78% | 45.44% | 44.47% | 47.65% | 46.22% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $271.9M | $259.9M | $259.6M | $265.4M | $270.3M | |
| Other Inc / (Exp) | $917K | $512K | $258K | -$274K | -$76K | |
| Operating Expenses | $264.5M | $252.4M | $253.1M | $260.2M | $265M | |
| Operating Income | $127.5M | $102.6M | $56.4M | $55M | $26.1M | |
| Net Interest Expenses | $15.1M | $14.8M | $8.9M | $4.8M | $4.7M | |
| EBT. Incl. Unusual Items | $113.3M | $88.3M | $47.7M | $49.9M | $21.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $27.1M | $20.4M | $11.7M | $11.9M | $5.8M | |
| Net Income to Company | $86.2M | $67.9M | $36M | $38M | $15.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $86.2M | $67.9M | $36M | $38M | $15.5M | |
| Basic EPS (Cont. Ops) | $1.96 | $1.66 | $0.95 | $1.04 | $0.43 | |
| Diluted EPS (Cont. Ops) | $1.96 | $1.66 | $0.95 | $1.04 | $0.43 | |
| Weighted Average Basic Share | $43.4M | $40.3M | $37.1M | $35.9M | $35.3M | |
| Weighted Average Diluted Share | $43.5M | $40.3M | $37.1M | $35.9M | $35.3M | |
| EBITDA | $152.8M | $117.7M | $73.1M | $72.7M | $42.4M | |
| EBIT | $128.6M | $103.5M | $57.3M | $57.9M | $29.2M | |
| Revenue (Reported) | $787.4M | $781.3M | $695.9M | $661.5M | $629.8M | |
| Operating Income (Reported) | $127.5M | $102.6M | $56.4M | $55M | $26.1M | |
| Operating Income (Adjusted) | $128.6M | $103.5M | $57.3M | $57.9M | $29.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.2B | $3.5B | $3.1B | $2.9B | $2.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.7B | $1.9B | $1.7B | $1.5B | $1.5B | |
| Gross Profit | $1.5B | $1.6B | $1.4B | $1.4B | $1.3B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.1B | $1.2B | $1.1B | $1.1B | $1.1B | |
| Other Inc / (Exp) | $5.4M | $4K | -$30.2M | $7.5M | -$33.4M | |
| Operating Expenses | $1.1B | $1.2B | $1.1B | $1.1B | $1.1B | |
| Operating Income | $395.8M | $472.2M | $341.9M | $322.1M | $255.8M | |
| Net Interest Expenses | $61.3M | $58.9M | $35.7M | $25.1M | $20.2M | |
| EBT. Incl. Unusual Items | $340M | $413.3M | $276.1M | $304.5M | $202.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $65.4M | $91.9M | $58M | $70M | $39.2M | |
| Net Income to Company | $274.6M | $321.5M | $218.1M | $234.5M | $163M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $274.6M | $321.5M | $218.1M | $234.5M | $163M | |
| Basic EPS (Cont. Ops) | $6.27 | $7.55 | $5.66 | $6.36 | $4.52 | |
| Diluted EPS (Cont. Ops) | $6.26 | $7.52 | $5.66 | $6.36 | $4.52 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $497.3M | $557.6M | $380.2M | $400M | $289.8M | |
| EBIT | $402.5M | $473.4M | $313.4M | $336.8M | $233.5M | |
| Revenue (Reported) | $3.2B | $3.5B | $3.1B | $2.9B | $2.8B | |
| Operating Income (Reported) | $395.8M | $472.2M | $341.9M | $322.1M | $255.8M | |
| Operating Income (Adjusted) | $402.5M | $473.4M | $313.4M | $336.8M | $233.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $787.4M | $781.3M | $695.9M | $661.5M | $629.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $395.4M | $426.2M | $386.4M | $346.3M | $338.7M | |
| Gross Profit | $392M | $355M | $309.5M | $315.2M | $291.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $271.9M | $259.9M | $259.6M | $265.4M | $270.3M | |
| Other Inc / (Exp) | $917K | $512K | $258K | -$274K | -$76K | |
| Operating Expenses | $264.5M | $252.4M | $253.1M | $260.2M | $265M | |
| Operating Income | $127.5M | $102.6M | $56.4M | $55M | $26.1M | |
| Net Interest Expenses | $15.1M | $14.8M | $8.9M | $4.8M | $4.7M | |
| EBT. Incl. Unusual Items | $113.3M | $88.3M | $47.7M | $49.9M | $21.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $27.1M | $20.4M | $11.7M | $11.9M | $5.8M | |
| Net Income to Company | $86.2M | $67.9M | $36M | $38M | $15.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $86.2M | $67.9M | $36M | $38M | $15.5M | |
| Basic EPS (Cont. Ops) | $1.96 | $1.66 | $0.95 | $1.04 | $0.43 | |
| Diluted EPS (Cont. Ops) | $1.96 | $1.66 | $0.95 | $1.04 | $0.43 | |
| Weighted Average Basic Share | $43.4M | $40.3M | $37.1M | $35.9M | $35.3M | |
| Weighted Average Diluted Share | $43.5M | $40.3M | $37.1M | $35.9M | $35.3M | |
| EBITDA | $152.8M | $117.7M | $73.1M | $72.7M | $42.4M | |
| EBIT | $128.6M | $103.5M | $57.3M | $57.9M | $29.2M | |
| Revenue (Reported) | $787.4M | $781.3M | $695.9M | $661.5M | $629.8M | |
| Operating Income (Reported) | $127.5M | $102.6M | $56.4M | $55M | $26.1M | |
| Operating Income (Adjusted) | $128.6M | $103.5M | $57.3M | $57.9M | $29.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.1B | $984.3M | $211.7M | $351.2M | $412.9M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $180.8M | $226.6M | $187.9M | $167.4M | $182.1M | |
| Inventory | $599.3M | $647.7M | $744.6M | $537.1M | $502.3M | |
| Prepaid Expenses | -- | -- | $15.9M | $14.1M | $19.4M | |
| Other Current Assets | $57.9M | $36.3M | $17.9M | $15.1M | $13.2M | |
| Total Current Assets | $1.9B | $1.9B | $1.2B | $1.1B | $1.1B | |
| Property Plant And Equipment | $855.4M | $703.8M | $682.2M | $711.5M | $758.1M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $211.8M | $212M | $209.3M | $210.5M | $206.9M | |
| Other Intangibles | $345.4M | $341.6M | $329M | $325.4M | $291.6M | |
| Other Long-Term Assets | $34M | $30.9M | $30.5M | $29.9M | $34M | |
| Total Assets | $3.4B | $3.2B | $2.4B | $2.4B | $2.4B | |
| Accounts Payable | $472.1M | $407M | $264.1M | $242.1M | $248.2M | |
| Accrued Expenses | $53.1M | $54.2M | $47.6M | $12.5M | $12.3M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $185.2M | $133.7M | $142.4M | $135.4M | $130.6M | |
| Other Current Liabilities | -- | -- | -- | $32.4M | $40.8M | |
| Total Current Liabilities | $792.5M | $717.2M | $528.9M | $511.9M | $508.8M | |
| Long-Term Debt | $989.5M | $991.4M | $616.6M | $497.4M | $498.1M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.5B | $2.2B | $1.6B | $1.5B | $1.6B | |
| Common Stock | $438K | $411K | $377K | $366K | $360K | |
| Other Common Equity Adj | -$32.8M | -$28.9M | -$34.3M | -$23.9M | -$43.7M | |
| Common Equity | $938M | $950.2M | $796.4M | $845.3M | $854.6M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $938M | $950.2M | $796.4M | $845.3M | $854.6M | |
| Total Liabilities and Equity | $3.4B | $3.2B | $2.4B | $2.4B | $2.4B | |
| Cash and Short Terms | $1.1B | $984.3M | $211.7M | $351.2M | $412.9M | |
| Total Debt | $989.5M | $991.4M | $616.6M | $497.4M | $498.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.1B | $702.3M | $157.7M | $267.6M | $320.8M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $234.6M | $267M | $222.1M | $219.8M | $196.1M | |
| Inventory | $560.7M | $679.7M | $613.9M | $473.4M | $474.1M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $63.3M | $64.4M | $47.2M | $51.8M | $50.2M | |
| Total Current Assets | $1.9B | $1.7B | $1B | $1B | $1B | |
| Property Plant And Equipment | $808.2M | $666.9M | $675.4M | $704.7M | $748.1M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $212.3M | $212.5M | $209.6M | $209.7M | $207.1M | |
| Other Intangibles | $344.4M | $340.7M | $328.1M | $324.5M | $291.5M | |
| Other Long-Term Assets | $27.7M | $29.1M | $27.5M | $29.8M | $36.1M | |
| Total Assets | $3.3B | $3B | $2.3B | $2.3B | $2.3B | |
| Accounts Payable | $334.8M | $284M | $180.2M | $191.4M | $199.1M | |
| Accrued Expenses | $16.8M | $16.6M | $5.9M | $5.1M | $4.8M | |
| Current Portion Of Long-Term Debt | -- | $495.7M | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $172.1M | $146.8M | $139.4M | $133.2M | $125.6M | |
| Other Current Liabilities | $32M | $29.3M | $27M | $23.9M | $25.2M | |
| Total Current Liabilities | $656.9M | $1B | $410.6M | $419M | $409.3M | |
| Long-Term Debt | $990M | $496.1M | $576.8M | $497.5M | $498.3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.3B | $2B | $1.5B | $1.4B | $1.5B | |
| Common Stock | $440K | $406K | $378K | $366K | $362K | |
| Other Common Equity Adj | -$31.5M | -$26.1M | -$30.4M | -$25.7M | -$43.1M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1B | $915.3M | $797.9M | $841.4M | $847.2M | |
| Total Liabilities and Equity | $3.3B | $3B | $2.3B | $2.3B | $2.3B | |
| Cash and Short Terms | $1.1B | $702.3M | $157.7M | $267.6M | $320.8M | |
| Total Debt | $990M | $991.8M | $576.8M | $497.5M | $498.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $109.7M | $339.7M | $250M | $232.5M | $185.5M | |
| Depreciation & Amoritzation | $94M | $94.1M | $65.3M | $64.1M | $57.9M | |
| Stock-Based Compensation | $12.8M | $21M | $21.9M | $19.5M | $17.8M | |
| Change in Accounts Receivable | $58.3M | -$46.5M | $32.7M | $15.5M | -$13.7M | |
| Change in Inventories | -$8.1M | -$52.9M | -$106.8M | $222.9M | $26.1M | |
| Cash From Operations | $588.5M | $268.3M | $88.4M | $529.1M | $298.8M | |
| Capital Expenditures | $32.9M | $37.4M | $40.4M | $59.9M | $56.2M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$31.5M | -$32.4M | -$40.4M | -$59.9M | -$56.2M | |
| Dividends Paid (Ex Special Dividend) | -$26.3M | -$60.1M | -$118.1M | -$112M | -$116.2M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.1B | -- | $240M | $70M | -- | |
| Long-Term Debt Repaid | -$744M | -- | -$620M | -$190M | -- | |
| Repurchase of Common Stock | -$45.3M | -$299.3M | -$299.7M | -$100M | -$50.5M | |
| Other Financing Activities | -$12.7M | -$4.2M | -$25.9M | -$5M | -$8.5M | |
| Cash From Financing | $324.8M | -$352.7M | -$819.3M | -$332.6M | -$174.8M | |
| Beginning Cash (CF) | $214.3M | $1.1B | $984.3M | $211.7M | $351.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $881.9M | -$116.9M | -$771.3M | $136.6M | $67.8M | |
| Ending Cash (CF) | $1.1B | $984.3M | $211.7M | $351.2M | $412.9M | |
| Levered Free Cash Flow | $555.6M | $230.8M | $48M | $469.3M | $242.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $86.2M | $67.9M | $36M | $38M | $15.5M | |
| Depreciation & Amoritzation | $24.1M | $14.2M | $15.7M | $14.8M | $13.3M | |
| Stock-Based Compensation | $6.9M | $5.9M | $4.3M | $5.2M | $9.8M | |
| Change in Accounts Receivable | -$54.5M | -$32.5M | -$24.9M | -$40.7M | -$8.6M | |
| Change in Inventories | $37.8M | -$27.7M | $134.1M | $61M | $27.1M | |
| Cash From Operations | -$39.5M | -$163.8M | $42.2M | -$25.6M | -$48.6M | |
| Capital Expenditures | $11.7M | $7.7M | $13.8M | $12M | $10.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$6.7M | -$7.7M | -$13.8M | -$12M | -$10.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -$30.6M | -$28.5M | -$29.3M | -$29M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$40M | -- | -- | |
| Repurchase of Common Stock | -- | -$74.5M | -$9.6M | -$9M | -- | |
| Other Financing Activities | -$3.6M | -$6.6M | -$4.8M | -$7.4M | -$4.6M | |
| Cash From Financing | -$2.8M | -$111.5M | -$82.8M | -$45.3M | -$33.6M | |
| Beginning Cash (CF) | $1.1B | $984.3M | $211.7M | $351.2M | $412.9M | |
| Foreign Exchange Rate Adjustment | $339K | $904K | $329K | -$722K | $449K | |
| Additions / Reductions | -$49M | -$282.9M | -$54.4M | -$82.9M | -$92.6M | |
| Ending Cash (CF) | $1.1B | $702.3M | $157.7M | $267.6M | $320.8M | |
| Levered Free Cash Flow | -$51.2M | -$171.5M | $28.4M | -$37.6M | -$59M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $274.6M | $321.5M | $218.1M | $234.5M | $163M | |
| Depreciation & Amoritzation | $94.7M | $84.2M | $66.8M | $63.2M | $56.3M | |
| Stock-Based Compensation | $17.8M | $20M | $20.4M | $20.3M | $22.4M | |
| Change in Accounts Receivable | -$19.1M | -$24.5M | $40.2M | -$349K | $18.4M | |
| Change in Inventories | $35.4M | -$118.4M | $55.1M | $149.8M | -$7.8M | |
| Cash From Operations | $563.3M | $144M | $294.4M | $461.4M | $275.7M | |
| Capital Expenditures | $36.5M | $33.4M | $46.5M | $58.1M | $54.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$30.1M | -$33.4M | -$46.5M | -$58.1M | -$54.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -$90.7M | -$116M | -$112.9M | -$115.8M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$660M | -$150M | -- | |
| Repurchase of Common Stock | -- | -$373.8M | -$234.8M | -$99.4M | -$41.5M | |
| Other Financing Activities | -$11.5M | -$7.3M | -$24.1M | -$7.6M | -$5.7M | |
| Cash From Financing | -$247.5M | -$461.4M | -$790.6M | -$295.2M | -$163.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $285.7M | -$350.9M | -$542.7M | $108.1M | $58.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $526.8M | $110.6M | $247.8M | $403.3M | $221.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $86.2M | $67.9M | $36M | $38M | $15.5M | |
| Depreciation & Amoritzation | $24.1M | $14.2M | $15.7M | $14.8M | $13.3M | |
| Stock-Based Compensation | $6.9M | $5.9M | $4.3M | $5.2M | $9.8M | |
| Change in Accounts Receivable | -$54.5M | -$32.5M | -$24.9M | -$40.7M | -$8.6M | |
| Change in Inventories | $37.8M | -$27.7M | $134.1M | $61M | $27.1M | |
| Cash From Operations | -$39.5M | -$163.8M | $42.2M | -$25.6M | -$48.6M | |
| Capital Expenditures | $11.7M | $7.7M | $13.8M | $12M | $10.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$6.7M | -$7.7M | -$13.8M | -$12M | -$10.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -$30.6M | -$28.5M | -$29.3M | -$29M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$40M | -- | -- | |
| Repurchase of Common Stock | -- | -$74.5M | -$9.6M | -$9M | -- | |
| Other Financing Activities | -$3.6M | -$6.6M | -$4.8M | -$7.4M | -$4.6M | |
| Cash From Financing | -$2.8M | -$111.5M | -$82.8M | -$45.3M | -$33.6M | |
| Beginning Cash (CF) | $1.1B | $984.3M | $211.7M | $351.2M | $412.9M | |
| Foreign Exchange Rate Adjustment | $339K | $904K | $329K | -$722K | $449K | |
| Additions / Reductions | -$49M | -$282.9M | -$54.4M | -$82.9M | -$92.6M | |
| Ending Cash (CF) | $1.1B | $702.3M | $157.7M | $267.6M | $320.8M | |
| Levered Free Cash Flow | -$51.2M | -$171.5M | $28.4M | -$37.6M | -$59M | |
Get CRI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CRI
Sector
P/E ratio
6.68x
16.92x
PEG ratio
0.45x
0.17x
P/B ratio
1.30x
1.42x
Price / LTM sales
0.38x
0.68x
Growth Metrics
CRI
Sector
Revenue growth
-4.79%
0.64%
Earnings growth
-58.65%
-1.02%
Revenue (5-year growth)
-4.17%
3.61%
Earnings forecast
$0.36
$0.24
Profitability
CRI
Sector
Profitability FY 2024
$1.4B
$456.7M
Return on invested capital
12.21%
4.58%
Return on assets
6.92%
2.72%
Return on equity
19.48%
6.7%
Earnings Date
Last Earnings Date
Apr
25
Next Earnings Date
Jul
25
Estimated Next Earnings Date
Jul
25
Balance Sheet
CRI
Sector
Total cash
$320.8M
$139.6M
Short term investments
--
$46.8M
Total assets
$2.4B
$1.4B
Long term debt
$498.3M
$128.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
